english
nederlands
Indymedia NL
Vrij Media Centrum Nederland
Indymedia NL is een onafhankelijk lokaal en mondiaal vrij communicatie orgaan. Indymedia biedt een andere kijk op het nieuws door een open publicatie methode van tekst, beeld & geluid.
> contact > zoek > archief > hulp > doe mee > publiceer nieuws > open nieuwslijn > disclaimer > chat
Zoek

 
Alle Woorden
Elk Woord
Bevat Media:
Alleen beelden
Alleen video
Alleen audio

Dossiers
Agenda
CHAT!
LINKS

European NewsReal

MDI klaagt Indymedia.nl aan
Rechtszaak Deutsche Bahn tegen Indymedia.nl
Onderwerpen
anti-fascisme / racisme
europa
feminisme
gentechnologie
globalisering
kunst, cultuur en muziek
media
militarisme
natuur, dier en mens
oranje
vrijheid, repressie & mensenrechten
wereldcrisis
wonen/kraken
zonder rubriek
Events
G8
Oaxaca
Schinveld
Schoonmakers-Campagne
Hulp
Hulp en tips voor beginners
Een korte inleiding over Indymedia NL
De spelregels van Indymedia NL
Hoe mee te doen?
Doneer
Steun Indymedia NL financieel!
Rechtszaken kosten veel geld, we kunnen elke (euro)cent gebruiken!

Je kunt ook geld overmaken naar bankrekening 94.32.153 tnv Stichting Vrienden van Indymedia (IBAN: NL41 PSTB 0009 4321 53).
Indymedia Netwerk

www.indymedia.org

Projects
print
radio
satellite tv
video

Africa
ambazonia
canarias
estrecho / madiaq
kenya
nigeria
south africa

Canada
hamilton
london, ontario
maritimes
montreal
ontario
ottawa
quebec
thunder bay
vancouver
victoria
windsor
winnipeg

East Asia
burma
jakarta
japan
manila
qc

Europe
alacant
andorra
antwerpen
armenia
athens
austria
barcelona
belarus
belgium
belgrade
bristol
bulgaria
croatia
cyprus
estrecho / madiaq
euskal herria
galiza
germany
grenoble
hungary
ireland
istanbul
italy
la plana
liege
lille
madrid
malta
marseille
nantes
netherlands
nice
norway
oost-vlaanderen
paris/île-de-france
poland
portugal
romania
russia
scotland
sverige
switzerland
thessaloniki
toulouse
ukraine
united kingdom
valencia
west vlaanderen

Latin America
argentina
bolivia
brasil
chiapas
chile
chile sur
colombia
ecuador
mexico
peru
puerto rico
qollasuyu
rosario
santiago
tijuana
uruguay
valparaiso

Oceania
adelaide
aotearoa
brisbane
burma
darwin
jakarta
manila
melbourne
oceania
perth
qc
sydney

South Asia
india
mumbai

United States
arizona
arkansas
atlanta
austin
baltimore
big muddy
binghamton
boston
buffalo
charlottesville
chicago
cleveland
colorado
columbus
danbury, ct
dc
hampton roads, va
hawaii
houston
hudson mohawk
idaho
ithaca
kansas city
la
madison
maine
miami
michigan
milwaukee
minneapolis/st. paul
new hampshire
new jersey
new mexico
new orleans
north carolina
north texas
nyc
oklahoma
omaha
philadelphia
pittsburgh
portland
richmond
rochester
rogue valley
saint louis
san diego
san francisco
san francisco bay area
santa barbara
santa cruz, ca
seattle
tallahassee-red hills
tampa bay
tennessee
united states
urbana-champaign
utah
vermont
western mass
worcester

West Asia
armenia
beirut
israel
palestine

Topics
biotech

Process
discussion
fbi/legal updates
indymedia faq
mailing lists
process & imc docs
tech
volunteer
Credits
Deze site is geproduceerd door vrijwilligers met free software waar mogelijk.

De software die we gebruiken is beschikbaar op: mir.indymedia.de
een alternatief is te vinden op: active.org.au/doc

Dank aan indymedia.de en mir-coders voor het creëren en delen van mir!

Contact:
info @ indymedia.nl
Novartis USA – Paulo Costa one of the worst managers
A.L.F. Crime Investigation Agency (CIA) - 08.05.2008 17:35

This information campaign is dedicated to the victims of Novartis AG. Murder, fraud, corruption, animal torture, greed, exploitation... think of anything evil and you think of Novartis and its subsidiaries Ciba Vision, Syngenta, Lek, Intercell and many more.

Brothers in Crime: Novartis and HLS
Brothers in Crime: Novartis and HLS

Novartis Imutran Xenotransplantation Experiment
Novartis Imutran Xenotransplantation Experiment

Novartis and Covance
Novartis and Covance




Novartis Basel, Switzerland, Torture Lab NIBR
Novartis Basel, Switzerland, Torture Lab NIBR

Part 11: Novartis: PETA Names the 10 Worst CEOs for Animals in Laboratories

Despite thousands of dead animals and millions of dollars spent by Novartis and its subsidiaries to develop animal organs for transplantation into humans, the company will never be able to transplant a soul or any compassion into CEO Paulo Costa. Pointless and painful experiments in xenotransplantation—transplanting the organs of one species into another species—have been one of the greatest medical disasters of all time.
Peddling transgenic pig parts and other organs designed to replace human parts is very profitable. The fact that these transplants are prohibitively expensive, of limited value, and always deadly hasn't slowed Costa's search for an immunopig.
Six thousand people are on waiting lists for human organs; while the problem of organ shortage could largely be solved through default consent to organ donation when people die, the use of animals as warehouses for spare parts continues. One hundred years of failed research shows that animals—even if they have transplanted human genes—do not have suitable spare parts for humans. Pigs are now being genetically manipulated to carry human genes in the hope that this catalog of failure and misery can be turned into a viable form of medical treatment. Other animals—such as hamsters, rabbits, and monkeys—have also been subjected to horrific and pointless transplantation experiments. But animals were never meant to be wrecking yards for human parts. All attempts to carry out animal-to-human organ transplants have failed. These surgeries are so monumentally unsuccessful that the animals usually begin to die within minutes of receiving an organ.
In Novartis' experiments, monkeys have endured lethal infections, lethal blood clotting, bleeding complications, viral and protozoal infections, lymph cancer, severe nausea, severe stomach inflammation and diarrhea, dehydration, fatal pneumonia, persistent wound infections, breakdowns, brain trauma, heart attacks, pneumonia, and anemia. Huge doses of immune-suppressing drugs have caused internal hemorrhaging.
A swab left in a monkey's abdomen by a Novartis employee caused a lethal infection, and similar incidents occurred on a regular basis. Sometimes the hearts or kidneys would simply not function after transplantation, and some pig organs were rejected almost instantaneously, undermining the only difference between genetically modified pigs and normal pigs. Victims of these gruesome experiments were overdosed with anesthetics, and their spleens were removed. One pig's kidney was accidentally transplanted into the abdomen of a monkey, and the primate died shortly afterward. If monkeys and baboons survived surgery, they faced death by organ rejection and failure, infections resulting from drug toxicity, or severely impaired immune systems.
The danger isn't only a risk for the animals used in the experiments. Some viruses carried by animals are impossible to eradicate and can infect humans—potentially with catastrophic results, such as the deadly influenza epidemic of 1918 that killed millions of people, mad cow disease, HIV, and the recent avian flu epidemic. This threatens human patients who would receive pig organs, and scientists across the globe are concerned that these viruses may pass into the general population, causing an epidemic that could affect all of us.

Write to Costa, and let him know that Novartis' preposterous venture will never result in cures for ailing and aging humans:

Paulo Costa, CEO
Novartis Corporation
608 Fifth Ave.
New York, NY 10020

 http://www.stopanimaltests.com/f_ten_worst_ceo.asp

Here is one of the crimes committed to monkeys. Note: This research, if you can call this torture anything like that, is simply done to speed up worldwide use of cyclosporine. Most of the output is produced at Sandoz Kundl in Austria. 98% of the cyclosporine produced in Kundl is exported.

Title
Pharmacokinetics of cyclosporine in monkeys after oral and intramuscular administration: relation to efficacy in kidney allografting

H.-J. Schuurman, K. Mennninger, M. Odeh, W. Slingerland, M. Ossevoort, M. Jonker, J.-C. Hengy, B. Dorobek, J. Vonderscher, J. Ringers, H.-J. Schuurman (2001) Pharmacokinetics of cyclosporine in monkeys after oral and intramuscular administration: relation to efficacy in kidney allografting
Transplant International 14 (5) , 320–328 doi:10.1111/j.1432-2277.2001.tb00066.x

Abstract

In cynomolgus and rhesus monkeys, the dose-normalized exposure of cyclosporine administered orally as microemulsion preconcen-trate (Neoral) was lower than that upon intramuscular administration. For oral administration, mean values (± SD) of Cmax, 24-h area-under-the curve (AUC) and 24-h trough level, all normalized for a 1 mg/kg dose, were 20 ± 9 ng kg/mg ml, 210 ± 70 ng h kg/mg ml and 2.6 ± 0.9 ng kg/mg ml, respectively. For intramuscular administration, levels were about 5.5-fold, 9-fold and 22-fold higher. Based on phar-macokinetic data, the efficacy of oral cyclosporine treatment (without any other immunosuppressant) was evaluated in life-supporting cynomolgus monkey kidney allotransplantation. Rejection-free kidney allograft survival could be achieved using oral cyclosporine monotherapy with average 24-h trough concentrations above 100 ng/ml during maintenance treatment. Typically, daily oral doses of 100 mg/kg-150 mg/kg during the first two weeks post-transplantation, followed by daily 30 mg/kg-100 mg/kg dose levels during subsequent maintenance can result in long-term allograft survival, with 24-h average trough levels in individual animals during maintenance between 110 ng/ml and 700 ng/ml.

Place
The experiments took place at the BPRC Biomedical Primate Research Centre, Rijswijk, The Netherlands

The „researching“ torturers
* H.-J. Schuurman, 1Transplantation Research, Novartis Pharma AG, 4002 Basel, Switzerland
* K. Menninger, 1Transplantation Research, Novartis Pharma AG, 4002 Basel, Switzerland
* M. Odeh, 1Transplantation Research, Novartis Pharma AG, 4002 Basel, Switzerland
* W. Slingerland, 2Biomedical Primate Research Centre, 2280 GH Rijswijk, The Netherlands
* M. Ossevoort, 2Biomedical Primate Research Centre, 2280 GH Rijswijk, The Netherlands
* M. Jonker, 2Biomedical Primate Research Centre, 2280 GH Rijswijk, The Netherlands
* J.-C. Hengy, 3Department of Drug Metabolism and Pharmacokinetics, Novartis Pharma AG, 4002 Basel, Switzerland
* B. Dorobek, 3Department of Drug Metabolism and Pharmacokinetics, Novartis Pharma AG, 4002 Basel, Switzerland
* J. Vonderscher, 3Department of Drug Metabolism and Pharmacokinetics, Novartis Pharma AG, 4002 Basel, Switzerland
* J. Ringers, 4Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands
* H.-J. Schuurman, 5Immerge BioTherapeutics, Building 75, 3rd Avenue, Charlestown, MA02129, USA

1Transplantation Research, Novartis Pharma AG, 4002 Basel, Switzerland
2Biomedical Primate Research Centre, 2280 GH Rijswijk, The Netherlands
3Department of Drug Metabolism and Pharmacokinetics, Novartis Pharma AG, 4002 Basel, Switzerland
4Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands
5Immerge BioTherapeutics, Building 75, 3rd Avenue, Charlestown, MA02129, USA

Contact
 henk.schuurman@immergebt.com
Tel. +1-617-241-5565
Fax +1-617-241-0539

More Novartis Crimes:
inform the public about more scandals of Novartis
 http://groups.google.com/group/novartis-crimes


- E-Mail: alfcia_vries@mail2world.com Website: http://www.novartiskills.eu
 

Lees meer over: natuur, dier en mens

aanvullingen
> indymedia.nl > zoek > archief > hulp > doe mee > publiceer nieuws > open nieuwslijn > disclaimer > chat
DISCLAIMER: Indymedia NL werkt volgens een 'open posting' principe om zodoende de vrijheid van meningsuiting te bevorderen. De berichten (tekst, beelden, audio en video) die gepost zijn in de open nieuwslijn van Indymedia NL behoren toe aan de betreffende auteur. De meningen die naar voren komen in deze berichten worden niet zonder meer door de redactie van Indymedia NL gesteund. Ook is het niet altijd mogelijk voor Indymedia NL om de waarheid van de berichten te garanderen.